Predictors of Outcome in t-PA Treated Stroke.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01498042|
Recruitment Status : Completed
First Posted : December 23, 2011
Last Update Posted : December 23, 2011
Stroke is among the most disabilitating diseases worldwide in terms of numbers affected and its consequences. A relatively new and well documented treatment of acute ischemic stroke today is tPA (tissue plasminogen activator; will be called thrombolysis from now on) Unfortunately only a minority of patients is given this treatment.
The large randomised controlled trials that investigated the safety and efficacy of thrombolytic therapy in treatment of acute stroke did not include patients over 80 years. In an aging population in the western world it will be of importance to investigate whether this treatment is safe and effective in this group.
Both Sorlandet hospital Kristiansand Norway and Bergen hospital have administered thrombolysis to selected patients over 80 years the last years. In addition there has been a registration of patients in stroke registers at both locations. This lays a foundation for further investigation. In association with Bergen the investigators have included 77 patients over 80 years treated with thrombolysis. In addition the investigators have 85 patients treated with tpa below 80 years. In our cohort the investigators are going to compare outcome in the 2 groups. In addition the investigators are going to perform a regression analysis of selected variables to see if there is an association of those variables with predefined outcome measures. Our outcome measures is as follows: mRS=6 (death)and mRS 0-1(good outcome) on 3 months control. The third outcome measure will be developement of sICH secondary to tPA treatment. As definition of sICH we have chosen the same definition as Ecass.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||162 participants|
|Official Title:||Ischemic Stroke Treated With iv Thrombolysis Within 4.5 Hours: Predictors of Outcome in a Cohort With a Large Proportion of Patients Above 80 Years|
|Study Start Date :||January 2007|
|Actual Primary Completion Date :||February 2010|
|Actual Study Completion Date :||February 2010|
stroke, thrombolysis, over 80, outcome
To study the outcome of stroke patients over 80 years treated with thrombolysis.
- Intravenous thrombolysis for acute ischemic stroke with 4.5 hours time-window and no upper age limit [ Time Frame: 2007-2010 (3 yrs) ]Functional outcome and complications 3 months after thrombolysis in patients over 80 and under 80 years.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01498042
|Sørlandet sykehus HF|
|Kristiansand, Norway, 4600|
|Study Chair:||Aase Mygland, MD, PhD||Sørlandet sykehus HF|